These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13534225)

  • 1. LSD-like delirium following ingestion of a small amount of its brom analog (BOL-148).
    RICHARDS N; CHAPMAN LF; GOODELL H; WOLFF HG
    Ann Intern Med; 1958 May; 48(5):1078-82. PubMed ID: 13534225
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148).
    GINZEL KH; MAYER-GROSS W
    Nature; 1956 Jul; 178(4526):210. PubMed ID: 13348662
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic trials in psychosis. III. Addendum-2-brom-d-lysergic acid diethylamide (BOL).
    TURNER WJ; ALMUDEVAR M; MERLIS S
    Am J Psychiatry; 1959 Sep; 116():261-2. PubMed ID: 13839967
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapeutic trials in psychosis. III. 2-Brom-d-lysergic acid diethylamide (BOL 148).
    TURNER WJ; MERLIS S
    Am J Psychiatry; 1958 Feb; 114(8):751-2. PubMed ID: 13498199
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE MICROSYNTHESIS OF 82BR-LABELLED 2-BROM-D-LYSERGIC ACID DIETHYLAMIDE (BOL).
    KALBHEN DA
    Med Exp Int J Exp Med; 1963; 9():20-4. PubMed ID: 14046721
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959; 1():20-8. PubMed ID: 14405872
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 16. PRELIMINARY STUDIES OF THE DISTRIBUTION AND FATE OF BR82- LABELLED 2-BROM-D-LYSERGIC ACID DIETHYLAMIDE (BOL) IN THE HUMAN BODY.
    KALBHEN DA; SARGENT TW
    Med Exp Int J Exp Med; 1963; 8():200-8. PubMed ID: 14044341
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of lysergic acid diethylamide (LSD 25), its 2-brom derivative (BOL 148) and of 5-hydroxytryptamine (5-HT) on the peristaltic reflex of the guinea-pig ileum.
    GINZEL KH
    J Physiol; 1957 Jul; 137(2):62P-3. PubMed ID: 13449894
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemical structure and lysergic acid derivative psychoses].
    SOLMS H
    Praxis; 1956 Aug; 45(32):746-9. PubMed ID: 13359249
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with lysergic acid diethylamide (LSD 25)].
    GUEDES PL
    Arq Neuropsiquiatr; 1961 Mar; 19():28-34. PubMed ID: 13709401
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of LSD and some analogues on the responses of single cortical neurons of the cat to optical stimulation.
    Dray A; Fox PC; Hilmy M; Somjen GG
    Brain Res; 1980 Oct; 200(1):105-21. PubMed ID: 6106524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.